Analysis of the Efficacy of Cardiac Ischemic Postconditioning With New Clinical End-points Using Novel Biomarkers

NCT ID: NCT04824716

Last Updated: 2021-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-14

Study Completion Date

2018-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present study was to investigate the efficacy of ischemic postconditioning in acute myocardial infarction patients. The safety of patients enrolled in the study was ensured during the entire study. Over 18 years old men and women were enrolled in the study who arrived to 2 of the most acknowledged Hungarian cardiac centres due to acute myocardial infarction and fulfilled all inclusion and exclusion criteria as per protocol. Patients in the order of their arrival were assigned either to control or post conditioned groups by turns. Medical treatment of the control group was done according to standard Percutaneous Coronary Intervention (PCI) guidelines, i.e. there was no further intervention after artery opening for 8 minutes, then stenting was performed. In the post conditioned group, after reperfusion has been confirmed, the coronary artery was occluded by inflation of the stent balloon 4 times (for 1-1 minute) followed by 1-1-minute reperfusion repeatedly to induce ischemic postconditioning. Postconditioning procedure was followed by stenting as in the control group. All other interventions and treatments in both patient groups were identical according to guidelines.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Over 18 years old men and women were enrolled in the study who arrived to 2 of the most acknowledged Hungarian cardiac centres due to acute myocardial infarction and fulfilled all inclusion and exclusion criteria as per protocol. Patients in the order of their arrival were assigned either to control or post conditioned groups by turns. After closing patient enrolment, further subgrouping will be performed in case sufficient group size has been achieved as follows: (1) normal, control, (2) normal, post conditioned, (3) hypercholesterolemic, not treated with statins, control, (4) hypercholesterolemic, not treated with statins, post conditioned, (5) statin treated, control, (6) statin treated, post conditioned.

Characterisation of postconditioning is performed by the following parameters:

1. Blood tests 5 minutes before as well as 8, 60 minutes, 24 hours, and 3 months after PCI to measure nitrotyrosine, a biomarker of peroxynitrite formation (nitrosative stress) by ELISA; B-type natriuretic peptide, a biomarker of heart failure by ELISA; matrix metalloproteinase activities (MMP-2 and MMP-9) putative biomarkers of cardiac remodelling by zymography; microRNA expression pattern by sequencing and its validation by quantitative real-time polymerase chain reaction (PCR).
2. Routine laboratory tests 6, 12 and 48 hours after PCI including creatine kinase (CKMB) and cardiac troponin T (cTnT).
3. ECG immediately after recanalization and intervention after 60 and 90 minutes, then 12, 24, 36 and 48 hours later 12-lead ECG is registered.
4. Echocardiography: 48 hours after intervention, standard view to judge left ventricle segments movement disorders
5. Angiography: Blush, Syntax score, and ischemic risk zone (area at risk, AAR) are determined
6. cardiac late enhancement magnetic resonance (MR) imaging to determine infarct size

At 3-month follow-up visit the following parameters were measured: echocardiography for restitution assessment, cardiac late enhancement MR imaging to determine infarct size and cardiac function, blood sampling for above mentioned biochemical laboratory tests

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Myocardial Infarction With ST Elevation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

postconditioning

Patients that underwent postconditioning after primary percutaneous coronary intervention.

Group Type EXPERIMENTAL

Postconditioning

Intervention Type PROCEDURE

The protocol of primary PCI followed by stenting is executed according to the descriptions according to the majority of relevant scientific literature on postconditioning studies and in accordance with the most recent guidelines. In the post conditioned group, after recanalization, the artery is occluded by inflation of stent balloon (4 times for 1-1 minute) followed by 1-1-minute reperfusion, repeatedly. Eight minutes after the start of examination, angiography is made in order to determine blood flow. Intervention is finished by the operator and another angiographic image is made (identical to initial standard projection).

control

Patients that underwent primary percutaneous coronary intervention.

Group Type OTHER

Percutaneous coronary intervention

Intervention Type DEVICE

Percutaneous coronary intervention as per European Society of Cardiology guidelines.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Postconditioning

The protocol of primary PCI followed by stenting is executed according to the descriptions according to the majority of relevant scientific literature on postconditioning studies and in accordance with the most recent guidelines. In the post conditioned group, after recanalization, the artery is occluded by inflation of stent balloon (4 times for 1-1 minute) followed by 1-1-minute reperfusion, repeatedly. Eight minutes after the start of examination, angiography is made in order to determine blood flow. Intervention is finished by the operator and another angiographic image is made (identical to initial standard projection).

Intervention Type PROCEDURE

Percutaneous coronary intervention

Percutaneous coronary intervention as per European Society of Cardiology guidelines.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subject must be \>18 years of age
2. Myocardial infarction with elevated ST
3. Chest pain onset less than 12 hours before PCI
4. concordant ST elevation (\>0,1 mV) in at least 2 ECG leads
5. Occluded main proximal or middle main coronary ('Thrombolysis In Myocardial Infarction' flow grade: 0) diagnosed with coronarography
6. Coronary opened by PCI (TIMI 2 flow grade)
7. Awake, conscious, co-operating patient, who is able to retain his breath for 10 sec
8. Signed Patient Information Leaflet and Patient Informed Consent Form

Exclusion Criteria

1. Cardiogenic shock
2. Previous myocardial infarction in the area of the occluded coronary artery
3. Occluded coronary with visible collateral branches
4. Lack of co-operation
5. Current left or right bundle branch block (LBBB)
6. Malignant ventricle arrhythmia or atrial fibrillation
7. Killip class \> 2
8. Known renal failure
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Semmelweis University Heart and Vascular Center

OTHER

Sponsor Role collaborator

Szeged University

OTHER

Sponsor Role collaborator

Peter Ferdinandy

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Peter Ferdinandy

professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Béla Merkely, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Heart and Vascular Center, Semmelweis University, Budapest

Peter Ferdinandy, MD, PhD, MBA

Role: STUDY_DIRECTOR

Pharmahungary Group

Imre Ungi, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Szeged, Faculty of Medicine, Cardiology Center, Department of Invasive Cardiology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Heart and Vascular Center, Semmelweis University

Budapest, , Hungary

Site Status

Pharmahungary Group

Szeged, , Hungary

Site Status

Department of Invasive Cardiology of Cardiology Center, Faculty of Medicine, University of Szeged

Szeged, , Hungary

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Hungary

Related Links

Access external resources that provide additional context or updates about the study.

http://www.pharmahungary.com

Website of Pharmahungary Group.

http://vszek.semmelweis.hu/homepage

Website of Semmelweis University Heart and Vascular Center.

http://www.med.u-szeged.hu/english

Website of Department of Invasive Cardiology of Cardiology Center, Faculty of Medicine, University of Szeged.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IPOST-01, v2.0, Nov 22, 2012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Delayed Postconditioning
NCT01483755 COMPLETED PHASE2